Osteopontin modulates angiotensin II–induced inflammation, oxidative stress, and fibrosis of the kidney
Talya Wolak(University of California, Los Angeles), Susanne B. Nicholas(University of California, Los Angeles), Jason Kim(University of California, Los Angeles), Nosratola D. Vaziri(University of California, Irvine), Hyun-Ju Kim(University of California, Irvine), Yuelan Ren(University of California, Los Angeles)
Cited by 117
Related Papers
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
MYH9 is associated with nondiabetic end-stage renal disease in African Americans
|Nature Genetics|2008|646
Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children
|JAMA Network Open|2019|256
Socioeconomic Disparities in Chronic Kidney Disease
|Advances in Chronic Kidney Disease|2015|252
Activation of Vascular Bone Morphogenetic Protein Signaling in Diabetes Mellitus
|Circulation Research|2010|194